Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novasep announced its API development and manufacturing site in Chasse-sur-Rhône, France, has been successfully inspected by the FDA.
read more
Novasep, a supplier of services and technologies for the life sciences industry, has finalized the set-up of its new synthesis laboratory and kilo lab at its US facility. Production of kilogram scale batches of synthetic molecules for biological ...
read more
Wednesday, December 13, 2017
Samsung BioLogics has been licensed by the Europe’s EMA for the first monoclonal antibody Drug Substance at its second plant.
read more
Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive ...
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by the "France Relance" Plan, to create a multipurpose pilot workshop within one of its production units.
read more
Novatek requalified as an approved supplier for Boehringer Ingelheim, a global leader in healthcare. Novatek regulatory compliant quality solutions are used at Boehringer Ingelheim for its human pharma, animal health and biopharmaceutical aseptic ...
read more
Novatek International has been selected by Boehringer Ingelheim as their approved Vendor and Partner for a worldwide solution for Environmental Monitoring Software.
read more
Catalent’s Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities.
read more
Novavax and FUJIFILM Diosynth Biotechnologies has announced an agreement to manufacture bulk drug substance for NVX-CoV2373, Novavax' COVID-19 vaccine candidate.
read more
Thursday, December 19, 2024
Catalent, Inc. and Novo Holdings A/S announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16.5 billion.
read more
Monday, November 13, 2017
Novo Nordisk has awarded Emerson a $40 million automation systems and services contract for a new U.S.-based drug manufacturing facility to address the global diabetes epidemic.
read more
Novo Nordisk and TetraScience have announced a new partnership to design a cloud-based instrument data platform for drug R&D, built natively on Amazon Web Services.
read more
Tuesday, February 13, 2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire ...
read more
Tuesday, November 24, 2015
US-Australian drug discovery company, Novogen Limited has engaged Novotech as the Contract Research Organization (CRO) to conduct its Phase 1 clinical study for the drug candidate, Cantrixil, which will commence in 2016.
read more